LRP5 and breast cancer: In a mouse model of mammary tumors and tibial osteolysis using C57BL/6 female mice, the co-injection of osteocytes to the mammary fat pad significantly reduced the size of mammary tumors and the anti-tumor effect was strengthened by the overexpression of Lrp5 (Figure 2A).